Protara Therapeutics TARA
NASDAQ TARA
$2.62 +0.19 (+7.82%)
At close: Nov 11, 2026 · 4:00 PM EST

Protara Therapeutics (TARA) Return on Equity [ROE] (2015 - 2026)

Updated

Protara Therapeutics (TARA) reported Return on Equity [ROE] of -41.03% for Q2 2026, down 6.87 percentage points from -34.16% a year earlier and down 7.37 percentage points from the prior quarter.

Analysis

Protara Therapeutics (TARA) Return on Equity [ROE] (2015 - 2026) Analysis & Trends

For FY2025, Protara Therapeutics posted Return on Equity [ROE] of -32.00%, up 6.21 percentage points from FY2024.

  • Return on Equity [ROE] has increased for three consecutive years, with a five-year change of +2.47 percentage points (FY2020 to FY2025).
  • By year, Return on Equity [ROE] came in at -38.21% in FY2024 (+9.23 pp), -47.44% in FY2023 (+1.68 pp), -49.12% in FY2022 (-22.95 pp) and -26.17% in FY2021 (+8.31 pp).
  • The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q3 2024.
  • Year over year, Return on Equity [ROE] gained in six of the last eight quarters, with an average year-over-year change of +14.12 percentage points.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q1 2025 (a gain of 38.60 percentage points); the low point was Q3 2023 (a drop of 57.68 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -33.66% (Q1 2026), -35.39% (Q4 2025) and -38.86% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Protara Therapeutics 149.62 Mn -411.27 Mn - -52.06%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -52.06%
Jun 30, 2026 -41.03%
Mar 31, 2026 -33.66%
Dec 31, 2025 -35.39%
Sep 30, 2025 -38.86%
Jun 30, 2025 -34.16%
Mar 31, 2025 -28.43%
Dec 31, 2024 -36.12%
Sep 30, 2024 -48.19%
Jun 30, 2024 -53.64%
Mar 31, 2024 -66.29%
Dec 31, 2023 -54.74%
Sep 30, 2023 -84.10%
Jun 30, 2023 -73.57%
Mar 31, 2023 -64.79%
Dec 31, 2022 -54.46%
Sep 30, 2022 -26.28%
Jun 30, 2022 -27.20%
Mar 31, 2022 -28.32%
Dec 31, 2021 -28.40%
API Access

Protara Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TARA&period=max&api_key=YOUR_API_KEY